Matthew Maxwell Donley - 02 Jan 2026 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role: Chief Operating Officer
Signature: /s/ Matthew Maxwell Donley
Issuer symbol: AUPH
Transactions as of: 02 Jan 2026
Net transactions value: -$682,453
Form type: 4
Filing time: 05 Jan 2026, 16:12:08 UTC
Previous filing: 04 Mar 2025
Next filing: 23 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Donley Matthew Maxwell	Chief Operating Officer	#140, 14315-118 AVENUE, EDMONTON, ALBERTA, CANADA	/s/ Matthew Maxwell Donley	05 Jan 2026	0001636642

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUPH	Common Stock	Award	$0	+54,166	+8%	$0.000000	734,631	02 Jan 2026	Direct	F1
transaction	AUPH	Common Stock	Tax liability	$682,453	-42,787	-5.8%	$15.95	695,801	02 Jan 2026	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares earned upon certification of performance for a performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2025 and December 31, 2026.
F2	Represents shares withheld to satisfy tax withholding obligations upon the vesting of performance awards.
F3	Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,500 common shares were acquired on May 30, 2025 and 1,457 common shares were acquired on November 28, 2025.